Showing results (621-630 of 706) with videos related to

Sort By:
Pageof 71
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) studyS Cook, P Vermersch, G Comi, et al.
BMC Neurology|July 28, 2016
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension studyRalf Gold, Ernst-Wilhelm Radue, Gavin Giovannoni, et al.
Immunological Investigations|January 1, 1997
Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipientsM J Evans, Y Edwards-Spring, J Myers, et al.
The EMBO Journal|September 25, 2020
Open conformation of tetraspanins shapes interaction partner networks on cell membranesYihu Yang, Xiaoran Roger Liu, Zev J Greenberg, et al.
Headache|February 18, 2009
Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine interventionRoger K Cady, Frederick G Freitag, Ninan T Mathew, et al.
The Laryngoscope|November 24, 2011
Linking expression of FOXM1, CEP55 and HELLS to tumorigenesis in oropharyngeal squamous cell carcinomaJeffrey R Janus, Rebecca R Laborde, Alexandra J Greenberg, et al.
Experimental Hematology|July 12, 2020
TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98-HOXD13 mouse model of MDSDarlene A Monlish, Zev J Greenberg, Sima T Bhatt, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
CRP Monitoring in Early Hospitalization: Implications for Predicting Outcomes in Patients with COVID-19Byron Avihai, Erin P Sundel, Eileen Lee, et al.
Radiology|June 1, 1976
A noninvasive technique for the study of cardiac hemodynamics utilizing C15-O2 inhalationD D Watson, P J Kenny, H Gelband, et al.
Headache|April 21, 2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS)Frederick G Freitag, Gary Finlayson, Alan M Rapoport, et al.
Pageof 71